AACR 2018 -- The development of robust platforms that enable phospho-protein-based analysis of cell signaling in the tumor microenvironment is pivotal for small molecule drug development. Currently lacking are reliable applications that can simultaneously measure multiple phospho-proteins in both tumor cells and immune cells ex vivo.

AACR 2019 -- Ovarian cancer (OC) is a gynecological malignancy with a high mortality rate of over 14,000 deaths annually in the U.S. Even though ~80% of OC patients initially go into remission after first line treatment (surgery and chemotherapy), more than 60% relapse within 16-18 months.

AACR 2019 -- Radiation therapy (RT) is a highly utilized clinical treatment modality with more than 50% of all cancer patients receiving some type of radiotherapy during the course of their illness. Appropriate systems and models to test preclinical radiation combinations are needed.